Author:
Cinausero Marika,Rihawi Karim,Cortiula Francesco,Follador Alessandro,Fasola Gianpiero,Ardizzoni Andrea
Reference129 articles.
1. Phase I and pharmacokinetic study of imatinib mesylate (Gleevec) and gemcitabine in patients with refractory solid tumors;Ali;Clin. Cancer Res.,2007
2. Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial;Alley;Lancet Oncol.,2017
3. Immunotherapy and radiation therapy for malignant pleural mesothelioma;Alley;Transl. Lung Cancer Res.,2017
4. WOG S0905: a randomized phase II study of cediranib versus placebo in combination with cisplatin and pemetrexed in chemonaive patients with malignant pleural mesothelioma;Anne;J. Clin. Oncol.,2018
5. Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy-;Anon,2019
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献